Publications

Dalbavancin (formerly BI397) Activity Against Selected Populations of Antimicrobial-Resistant Gram-Positive Pathogens, Lead author: Jones RN, presented at 41st annual Infectious Diseases Society of America (IDSA), October 9 – 12, 2003, San Diego, CA

Antimicrobial Activity of Daptomycin Against Multi-Drug Resistant Gram-Positive Strains Collected Worldwide, Lead author: Sader HS, presented at 41st annual Infectious Diseases Society of America (IDSA), October 9 – 12, 2003, San Diego, CA

In Vitro Activity of the Novel Des-F(6)-Quinolone, Garenoxacin, Against 27,831 Community Acquired Respiratory Tract Infection (CARTI) Pathogens: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 41st annual Infectious Diseases Society of America (IDSA), October 9 – 12, 2003, San Diego, CA

PK-PD Evaluation of Doripenem Against Extended Spectrum Beta-Lactamase Production Enterobacteraceae, Lead author: Andes DR, presented at 41st annual Infectious Diseases Society of America (IDSA), October 9 – 12, 2003, San Diego, CA

Comparative Activity and Spectrum of Broad-Spectrum Beta-Lactams Tested Against 12,295 Staphylococci and Streptococci: Report from the SENTRY Antimicrobial Surveillance Program (North America: 2001-2002), Lead author: Fritsche TR, presented at 41st annual Infectious Diseases Society of America (IDSA), October 9 – 12, 2003, San Diego, CA

Global Patterns of Susceptibility for 21 Commonly Used Antimicrobial Agents Tested Against 48,440 Enterobacteraceae in the SENTRY Antimicrobial Surveillance Program (1997-2001), Lead author: Sader HS, presented at 41st annual Infectious Diseases Society of America (IDSA), October 9 – 12, 2003, San Diego, CA

Antimicrobial Susceptibility Pattern Comparisons Among Intensive Care Unit (ICU) and General Ward (Non-ICU) Gram-Negative Isolates from the MYSTIC Programme (USA; 1999-2002), Lead author: Rhomberg PR, presented at 41st annual Infectious Diseases Society of America (IDSA), October 9 – 12, 2003, San Diego, CA

Spectrum of Activity for Antimicrobials Tested Against Non-Fermentative Gram-Negative Bacilli (18,569 Strains) Isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001), Lead author: Jones RN, presented at 41st annual Infectious Diseases Society of America (IDSA), October 9 – 12, 2003, San Diego, CA

Molecular and Biochemical Characterization of a novel Class B beta-lactamase, GIM-1: a New Subclass of Metallo-beta-Lactamase: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Castanheira M, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Genetic Analysis of Salmonella spp. (SAL) with Resistance (R) to Extended-Spectrum Cephalosporins and Fluoroquinolones (FQ) Isolated in North and Latin America (SENTRY Antimicrobial Surveillance Program), Lead author: Biedenbach DJ, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Molecular Analysis and Activity Profiles of Fluoroquinolone (FQ)-Resistant (R) S. pneumoniae (SPN) Isolates from North America (NA), Latin America (LA) and Europe (EU): Results From the SENTRY Antimicrobial Surveillance Program (2001-2002), Lead author: Biedenbach DJ, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Increase in Fluoroquinolones Resistance Among Multiple Ciprofloxacin-Resistant Streptococcus pneumoniae Clones in Europe, Lead author: Morosini M, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Emerging Beta-lactamase-negative Ampicillin Resistant Haemophilus influenzae in Japan and South Africa, Lead author: Turnidge JD, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Low-Level Risk Assessment for Tylosin Use in Poultry and Swine on the Treatment of Human Food-borne Disease, Lead author: Doores S, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Trends in Mupirocin Resistance in Europe and USA Among 13,087 Staphylococcal and S. pyogenes Isolates, Lead author: Fritsche TR, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Trends in Antimicrobial Resistance Rates of Staphylococcus aureus Causing Bloodstream Infection and Nosocomial Pneumonia. A Report from the Euro-SENTRY program 2000-2002, Lead author: Rodriguez-Villalobos H, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Changing Patterns of Bacterial Pathogens and Their Antimicrobial Susceptibility Profiles in Patients Hospitalized with Pneumonia: Report from the SENTRY Antimicrobial Surveillance Program, 2002, Lead author: Fritsche TR, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Antimicrobial Susceptibility Patterns of Unusual Non-Fermenting Gram-negative Bacilli (NF-GNB) isolated from Latin America: Report from SENTRY Antimicrobial Surveillance Program (1997-2002), Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Resistance in Pathogens from Patients Admitted to Intensive Care Units (ICU): A Report from the SENTRY Surveillance Program, Europe 2000-2002, Lead author: Rodriguez-Villalobos H, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Antimicrobial Susceptibility (S) and Epidemiology of a Worldwide Collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001), Lead author: Kirby J, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

IMPs, VIMs and SPMs. The Great Diversity of Metallo-Beta-Lactamases Causing Carbapenem-Resistance Among Pseudomonas aeruginosa Isolates in a Brazilian Hospital, Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Characterisation of Mobile Elements Carrying Metallo-Beta-Lactamase (MBL) Genes, blaIMP-1, blaIMP-14, blaSPM-1, blaVIM-2 from Latin American Medical Centres: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Toleman MA, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Dissemination of Metallo-Beta-Lactamases in Europe via a Tn5051-like Composite Transposon: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Toleman MA, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Wide Dissemination of SPM-Like-Metallo-Beta-Lactamase among Carbapenem-Resistant Pseudomonas aeruginosa Strains Isolated in Brazilian Hospitals, Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Emergence and Dissemination of IMP-Like Metallo-Beta-Lactamase-Producing Acinetobacter spp. in a Brazilian Teaching Hospital, Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

The Emergence of Metallo-Beta-Lactamases (MBL) and Increasing Carbapenem Resistance Among P. aeruginosa (PSA) and Acinetobacter spp. (ASP) from Bloodstream Infections (BSI): Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Changing Susceptibility Patterns Among Escherichia coli in Latin America: 6-Year Report of the SENTRY Antimicrobial Surveillance Program, Lead author: Andrade SS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

First Annual Report from the Worldwide ZAAPS Oxazolidinone Resistance and Usage Surveillance Program (2002), Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Resistances in Aeromonas Species from the SENTRY Global Surveillance Program, 1997-2001, Lead author: Turnidge JD, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Evolution and Dissemination of Extended-Spectrum Beta-Lactamase-Producing K. pneumoniae (ESBL+KPN): Epidemiology and Molecular Report from the SENTRY Antimicrobial Surveillance Program During 1997-2003, Lead author: Biedenbach DJ, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

First Description of CTX-M Beta-Lactamase-Producing Klebsiella pneumoniae in Brazil, Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

High Rates of Macrolide Resistance and Emerging Quinolone Resistance inStreptococcus agalactiae in the Asia-Pacific Region, Lead author: Turnidge JD, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Recent Declines in Beta-Lactam and MLS_B Resistances Among S. pneumoniae and Age-Related Effects: Report from the SENTRY Antimicrobial Surveillance Program (North America [NA], 1997 – 2002), Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Penicillin and Macrolides Resistance Trends among Streptococcus pneumoniae Isolated in Latin America between 1998 and 2002: Report of SENTRY Antimicrobial Surveillance Program, Lead author: Andrade SS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

In Vitro Activity of Garenoxacin, a Novel Des-F(6)-Quinolone, Against 120,088 Clinical Isolates Collected Worldwide by the SENTRY Antimicrobial Surveillance Program (1999-2002), Lead author: Sader HS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Activity of AZD2563 and Comparator Agents Tested Against 6,444 Staphylococci, Streptococci and Enterococci (North America, 2001 – 2002), Lead author: Fritsche TR, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

In Vitro Activity of the Tigecycline, a New Glycylcycline, Tested against 1,326 Clinical Bacterial Strains Isolated from the Latin American Region, Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Enhanced Activity of Sitafloxacin against a Large Collection of Gram-positive Isolates From Latin America, Lead author: Andrade SS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

In Vitro Activity of Omiganan (OMI) Pentahydrochloride, a Topical Cationic Peptide, Tested Against Contemporary Bacteria and Yeast Isolates, Lead author: Sader HS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Contemporary In Vitro Synergy Rates for Aztreonam Combined with Newer Fluoroquinolones (FQ) and Beta-Lactams Tested Against Gram-Negative Bacilli, Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Worldwide Assessment of Dalbavancin (BI397) Activity and Spectrum (2002), Lead author: Stephen J, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Doripenem (S-4661), A Novel Carbapenem: Comparative Activity Against Contemporary Pathogens Including Anaerobes, Bactericidal Action and Methods Evaluations, Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Doripenem (S-4661), Antimicrobial Activity Tested Against Drug-Resistant Pathogens, Lead author: Huynh H, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

LB11058, a Novel Cephalosporin, Tested Against Neisseria gonorrhoeae Including Drug-Resistant Pathogens, Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Antimicrobial Activity of LB11058, A Novel Cephalosporin, Tested Against Staphylococci, Streptococci and Enterococci, Lead author: Sader HS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Antimicrobial Activity of LB11058 Tested Against S. pneumoniae, H. influenzae and M. catarrhalis, Lead author: Johnson DM, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Relationship Between Increased Levofloxacin (LEV) Use and Decreased Susceptibility of Streptococcus pneumoniae (SP): Report From the ARREST Program, Lead author: Bhavnani SM, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Risk Assessment of Macrolide Use in Fed Cattle on the Treatment of Human Food-borne Illness, Lead author: Hurd HS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Experience with ESBL-Producing Enterobacteriaceae (ENT) Treated with Carbapenems Compared to Other Beta-Lactams: Outcomes Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

The Emergence of the Extended-Spectrum Beta-Lactamase GES-1 in a Pseudomonas aeruginosa strain in Brazil: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois